nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Dactinomycin—germ cell cancer	0.0498	0.319	CbGbCtD
Carfilzomib—ABCB1—Vinblastine—germ cell cancer	0.0312	0.2	CbGbCtD
Carfilzomib—ABCB1—Cisplatin—germ cell cancer	0.0286	0.183	CbGbCtD
Carfilzomib—ABCB1—Etoposide—germ cell cancer	0.0281	0.18	CbGbCtD
Carfilzomib—ABCB1—Methotrexate—germ cell cancer	0.0186	0.119	CbGbCtD
Carfilzomib—PSMB2—skin epidermis—germ cell cancer	0.0141	0.0427	CbGeAlD
Carfilzomib—Tumour lysis syndrome—Ifosfamide—germ cell cancer	0.0117	0.0409	CcSEcCtD
Carfilzomib—Multi-organ failure—Dactinomycin—germ cell cancer	0.0109	0.038	CcSEcCtD
Carfilzomib—Multi-organ failure—Ifosfamide—germ cell cancer	0.00996	0.0348	CcSEcCtD
Carfilzomib—Pulmonary hypertension—Ifosfamide—germ cell cancer	0.00871	0.0305	CcSEcCtD
Carfilzomib—PSMB8—trigeminal ganglion—germ cell cancer	0.00774	0.0234	CbGeAlD
Carfilzomib—PSMB10—adrenal gland—germ cell cancer	0.00686	0.0208	CbGeAlD
Carfilzomib—PSMB5—trigeminal ganglion—germ cell cancer	0.00683	0.0207	CbGeAlD
Carfilzomib—PSMB10—female gonad—germ cell cancer	0.0064	0.0194	CbGeAlD
Carfilzomib—Neuritis—Vinblastine—germ cell cancer	0.00602	0.0211	CcSEcCtD
Carfilzomib—Hypomagnesaemia—Bleomycin—germ cell cancer	0.00598	0.0209	CcSEcCtD
Carfilzomib—PSMB1—trigeminal ganglion—germ cell cancer	0.00597	0.0181	CbGeAlD
Carfilzomib—PSMB10—endocrine gland—germ cell cancer	0.00595	0.018	CbGeAlD
Carfilzomib—PSMB10—head—germ cell cancer	0.00587	0.0178	CbGeAlD
Carfilzomib—PSMB2—trigeminal ganglion—germ cell cancer	0.00583	0.0177	CbGeAlD
Carfilzomib—PSMB1—embryo—germ cell cancer	0.00577	0.0175	CbGeAlD
Carfilzomib—PSMB8—decidua—germ cell cancer	0.00576	0.0174	CbGeAlD
Carfilzomib—PSMB10—testis—germ cell cancer	0.00567	0.0172	CbGeAlD
Carfilzomib—PSMB2—embryo—germ cell cancer	0.00563	0.017	CbGeAlD
Carfilzomib—Hypophosphataemia—Ifosfamide—germ cell cancer	0.00558	0.0195	CcSEcCtD
Carfilzomib—Tumour lysis syndrome—Methotrexate—germ cell cancer	0.00553	0.0194	CcSEcCtD
Carfilzomib—PSMB5—telencephalon—germ cell cancer	0.00537	0.0163	CbGeAlD
Carfilzomib—PSMB10—cerebellum—germ cell cancer	0.00524	0.0159	CbGeAlD
Carfilzomib—PSMB8—Vinorelbine—Vinblastine—germ cell cancer	0.00518	0.35	CbGdCrCtD
Carfilzomib—PSMB8—Podofilox—Etoposide—germ cell cancer	0.00518	0.35	CbGdCrCtD
Carfilzomib—PSMB1—eye—germ cell cancer	0.00515	0.0156	CbGeAlD
Carfilzomib—PSMB5—decidua—germ cell cancer	0.00509	0.0154	CbGeAlD
Carfilzomib—PSMB2—eye—germ cell cancer	0.00502	0.0152	CbGeAlD
Carfilzomib—PSMB2—retina—germ cell cancer	0.00498	0.0151	CbGeAlD
Carfilzomib—PSMB8—pituitary gland—germ cell cancer	0.00495	0.015	CbGeAlD
Carfilzomib—Hypophosphataemia—Cisplatin—germ cell cancer	0.00481	0.0168	CcSEcCtD
Carfilzomib—PSMB1—telencephalon—germ cell cancer	0.00469	0.0142	CbGeAlD
Carfilzomib—PSMB2—telencephalon—germ cell cancer	0.00458	0.0139	CbGeAlD
Carfilzomib—PSMB1—skin of body—germ cell cancer	0.00448	0.0136	CbGeAlD
Carfilzomib—PSMB5—uterus—germ cell cancer	0.00445	0.0135	CbGeAlD
Carfilzomib—PSMB1—decidua—germ cell cancer	0.00445	0.0135	CbGeAlD
Carfilzomib—PSMB8—Vincristine—Vinblastine—germ cell cancer	0.00443	0.3	CbGdCrCtD
Carfilzomib—PSMB8—adrenal gland—germ cell cancer	0.00442	0.0134	CbGeAlD
Carfilzomib—PSMB5—pituitary gland—germ cell cancer	0.00437	0.0132	CbGeAlD
Carfilzomib—PSMB2—skin of body—germ cell cancer	0.00437	0.0132	CbGeAlD
Carfilzomib—PSMB2—decidua—germ cell cancer	0.00434	0.0131	CbGeAlD
Carfilzomib—PSMB8—bone marrow—germ cell cancer	0.00428	0.013	CbGeAlD
Carfilzomib—PSMB10—brain—germ cell cancer	0.00426	0.0129	CbGeAlD
Carfilzomib—PSMB5—medulla oblongata—germ cell cancer	0.00422	0.0128	CbGeAlD
Carfilzomib—PSMB8—female gonad—germ cell cancer	0.00412	0.0125	CbGeAlD
Carfilzomib—PSMB10—lymph node—germ cell cancer	0.00411	0.0125	CbGeAlD
Carfilzomib—PSMB1—gonad—germ cell cancer	0.00392	0.0119	CbGeAlD
Carfilzomib—PSMB5—adrenal gland—germ cell cancer	0.0039	0.0118	CbGeAlD
Carfilzomib—PSMB1—uterus—germ cell cancer	0.00389	0.0118	CbGeAlD
Carfilzomib—PSMB5—midbrain—germ cell cancer	0.00385	0.0117	CbGeAlD
Carfilzomib—PSMB2—gonad—germ cell cancer	0.00382	0.0116	CbGeAlD
Carfilzomib—PSMB1—pituitary gland—germ cell cancer	0.00382	0.0116	CbGeAlD
Carfilzomib—PSMB2—uterus—germ cell cancer	0.0038	0.0115	CbGeAlD
Carfilzomib—PSMB5—bone marrow—germ cell cancer	0.00378	0.0114	CbGeAlD
Carfilzomib—PSMB5—spinal cord—germ cell cancer	0.00376	0.0114	CbGeAlD
Carfilzomib—PSMB2—pituitary gland—germ cell cancer	0.00373	0.0113	CbGeAlD
Carfilzomib—PSMB1—medulla oblongata—germ cell cancer	0.00369	0.0112	CbGeAlD
Carfilzomib—PSMB8—testis—germ cell cancer	0.00366	0.0111	CbGeAlD
Carfilzomib—PSMB5—female gonad—germ cell cancer	0.00364	0.011	CbGeAlD
Carfilzomib—PSMB2—medulla oblongata—germ cell cancer	0.0036	0.0109	CbGeAlD
Carfilzomib—PSMB1—adrenal gland—germ cell cancer	0.00341	0.0103	CbGeAlD
Carfilzomib—PSMB1—midbrain—germ cell cancer	0.00337	0.0102	CbGeAlD
Carfilzomib—PSMB2—adrenal gland—germ cell cancer	0.00333	0.0101	CbGeAlD
Carfilzomib—Bacterial infection—Methotrexate—germ cell cancer	0.00333	0.0116	CcSEcCtD
Carfilzomib—PSMB1—bone marrow—germ cell cancer	0.0033	0.01	CbGeAlD
Carfilzomib—PSMB2—midbrain—germ cell cancer	0.00329	0.00996	CbGeAlD
Carfilzomib—PSMB1—spinal cord—germ cell cancer	0.00329	0.00996	CbGeAlD
Carfilzomib—PSMB5—testis—germ cell cancer	0.00323	0.00978	CbGeAlD
Carfilzomib—PSMB2—bone marrow—germ cell cancer	0.00322	0.00976	CbGeAlD
Carfilzomib—PSMB2—spinal cord—germ cell cancer	0.00321	0.00972	CbGeAlD
Carfilzomib—PSMB1—female gonad—germ cell cancer	0.00318	0.00964	CbGeAlD
Carfilzomib—PSMB2—female gonad—germ cell cancer	0.0031	0.0094	CbGeAlD
Carfilzomib—Sepsis—Dactinomycin—germ cell cancer	0.00307	0.0108	CcSEcCtD
Carfilzomib—PSMB5—cerebellum—germ cell cancer	0.00298	0.00903	CbGeAlD
Carfilzomib—PSMB1—endocrine gland—germ cell cancer	0.00296	0.00896	CbGeAlD
Carfilzomib—PSMB1—head—germ cell cancer	0.00292	0.00885	CbGeAlD
Carfilzomib—PSMB2—endocrine gland—germ cell cancer	0.00289	0.00875	CbGeAlD
Carfilzomib—Hepatic failure—Dactinomycin—germ cell cancer	0.00286	0.01	CcSEcCtD
Carfilzomib—PSMB2—head—germ cell cancer	0.00285	0.00863	CbGeAlD
Carfilzomib—PSMB1—testis—germ cell cancer	0.00282	0.00855	CbGeAlD
Carfilzomib—Sepsis—Ifosfamide—germ cell cancer	0.00282	0.00986	CcSEcCtD
Carfilzomib—PSMB2—testis—germ cell cancer	0.00275	0.00834	CbGeAlD
Carfilzomib—PSMB8—brain—germ cell cancer	0.00274	0.00831	CbGeAlD
Carfilzomib—PSMB8—lymph node—germ cell cancer	0.00265	0.00803	CbGeAlD
Carfilzomib—Hepatic failure—Ifosfamide—germ cell cancer	0.00262	0.00917	CcSEcCtD
Carfilzomib—PSMB1—cerebellum—germ cell cancer	0.00261	0.0079	CbGeAlD
Carfilzomib—Renal failure acute—Ifosfamide—germ cell cancer	0.00255	0.00893	CcSEcCtD
Carfilzomib—PSMB2—cerebellum—germ cell cancer	0.00254	0.0077	CbGeAlD
Carfilzomib—Acute coronary syndrome—Vinblastine—germ cell cancer	0.00248	0.00868	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Vinblastine—germ cell cancer	0.00247	0.00863	CcSEcCtD
Carfilzomib—PSMB5—brain—germ cell cancer	0.00242	0.00734	CbGeAlD
Carfilzomib—Pain in extremity—Ifosfamide—germ cell cancer	0.00236	0.00824	CcSEcCtD
Carfilzomib—PSMB5—lymph node—germ cell cancer	0.00234	0.00709	CbGeAlD
Carfilzomib—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00232	0.0081	CcSEcCtD
Carfilzomib—Hypoaesthesia—Vinblastine—germ cell cancer	0.00225	0.00786	CcSEcCtD
Carfilzomib—Cardiac arrest—Ifosfamide—germ cell cancer	0.00224	0.00784	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Cisplatin—germ cell cancer	0.00224	0.00784	CcSEcCtD
Carfilzomib—Sepsis—Etoposide—germ cell cancer	0.00222	0.00778	CcSEcCtD
Carfilzomib—Blood creatinine increased—Ifosfamide—germ cell cancer	0.00221	0.00772	CcSEcCtD
Carfilzomib—Renal failure acute—Cisplatin—germ cell cancer	0.0022	0.0077	CcSEcCtD
Carfilzomib—Hypokalaemia—Ifosfamide—germ cell cancer	0.00214	0.0075	CcSEcCtD
Carfilzomib—Pneumonia—Bleomycin—germ cell cancer	0.00214	0.00748	CcSEcCtD
Carfilzomib—PSMB1—brain—germ cell cancer	0.00212	0.00641	CbGeAlD
Carfilzomib—Acute coronary syndrome—Bleomycin—germ cell cancer	0.00209	0.00733	CcSEcCtD
Carfilzomib—Neutropenia—Dactinomycin—germ cell cancer	0.00208	0.00727	CcSEcCtD
Carfilzomib—PSMB2—brain—germ cell cancer	0.00207	0.00626	CbGeAlD
Carfilzomib—Cardiac failure congestive—Etoposide—germ cell cancer	0.00205	0.00718	CcSEcCtD
Carfilzomib—PSMB1—lymph node—germ cell cancer	0.00205	0.0062	CbGeAlD
Carfilzomib—Hyponatraemia—Cisplatin—germ cell cancer	0.00204	0.00714	CcSEcCtD
Carfilzomib—PSMB2—lymph node—germ cell cancer	0.002	0.00605	CbGeAlD
Carfilzomib—Pneumonia—Dactinomycin—germ cell cancer	0.00199	0.00697	CcSEcCtD
Carfilzomib—Blood creatinine increased—Cisplatin—germ cell cancer	0.0019	0.00666	CcSEcCtD
Carfilzomib—Hypoaesthesia—Bleomycin—germ cell cancer	0.0019	0.00664	CcSEcCtD
Carfilzomib—Hypokalaemia—Cisplatin—germ cell cancer	0.00185	0.00647	CcSEcCtD
Carfilzomib—Hyperglycaemia—Ifosfamide—germ cell cancer	0.00184	0.00643	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.00183	0.0064	CcSEcCtD
Carfilzomib—Pneumonia—Ifosfamide—germ cell cancer	0.00183	0.00639	CcSEcCtD
Carfilzomib—Anaemia—Vinblastine—germ cell cancer	0.00182	0.00636	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.00179	0.00626	CcSEcCtD
Carfilzomib—Renal failure—Ifosfamide—germ cell cancer	0.00178	0.00625	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.00178	0.00623	CcSEcCtD
Carfilzomib—Cardiac arrest—Etoposide—germ cell cancer	0.00177	0.00619	CcSEcCtD
Carfilzomib—Leukopenia—Vinblastine—germ cell cancer	0.00176	0.00616	CcSEcCtD
Carfilzomib—Chills—Bleomycin—germ cell cancer	0.00171	0.00599	CcSEcCtD
Carfilzomib—Hypertension—Vinblastine—germ cell cancer	0.0017	0.00594	CcSEcCtD
Carfilzomib—Chills—Dactinomycin—germ cell cancer	0.0016	0.00558	CcSEcCtD
Carfilzomib—Thrombocytopenia—Vinblastine—germ cell cancer	0.00157	0.0055	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00154	0.0054	CcSEcCtD
Carfilzomib—Renal failure—Cisplatin—germ cell cancer	0.00154	0.00538	CcSEcCtD
Carfilzomib—Anaemia—Bleomycin—germ cell cancer	0.00153	0.00537	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00153	0.00537	CcSEcCtD
Carfilzomib—Anorexia—Vinblastine—germ cell cancer	0.00153	0.00535	CcSEcCtD
Carfilzomib—Cardiac disorder—Ifosfamide—germ cell cancer	0.00151	0.00529	CcSEcCtD
Carfilzomib—Neutropenia—Etoposide—germ cell cancer	0.0015	0.00526	CcSEcCtD
Carfilzomib—Leukopenia—Bleomycin—germ cell cancer	0.00149	0.0052	CcSEcCtD
Carfilzomib—Chills—Ifosfamide—germ cell cancer	0.00146	0.00512	CcSEcCtD
Carfilzomib—Cough—Bleomycin—germ cell cancer	0.00145	0.00507	CcSEcCtD
Carfilzomib—Pneumonia—Etoposide—germ cell cancer	0.00144	0.00505	CcSEcCtD
Carfilzomib—ABCB1—blood vessel—germ cell cancer	0.00144	0.00437	CbGeAlD
Carfilzomib—Anaemia—Dactinomycin—germ cell cancer	0.00143	0.00501	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Etoposide—germ cell cancer	0.00141	0.00495	CcSEcCtD
Carfilzomib—Renal failure—Etoposide—germ cell cancer	0.00141	0.00493	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Etoposide—germ cell cancer	0.00141	0.00492	CcSEcCtD
Carfilzomib—Decreased appetite—Vinblastine—germ cell cancer	0.00139	0.00488	CcSEcCtD
Carfilzomib—Leukopenia—Dactinomycin—germ cell cancer	0.00139	0.00485	CcSEcCtD
Carfilzomib—Pain—Vinblastine—germ cell cancer	0.00137	0.0048	CcSEcCtD
Carfilzomib—Constipation—Vinblastine—germ cell cancer	0.00137	0.0048	CcSEcCtD
Carfilzomib—Infection—Bleomycin—germ cell cancer	0.00135	0.00471	CcSEcCtD
Carfilzomib—Sepsis—Methotrexate—germ cell cancer	0.00133	0.00466	CcSEcCtD
Carfilzomib—Thrombocytopenia—Bleomycin—germ cell cancer	0.00133	0.00464	CcSEcCtD
Carfilzomib—Anaemia—Ifosfamide—germ cell cancer	0.00131	0.00459	CcSEcCtD
Carfilzomib—Cardiac disorder—Cisplatin—germ cell cancer	0.0013	0.00456	CcSEcCtD
Carfilzomib—Anorexia—Bleomycin—germ cell cancer	0.00129	0.00452	CcSEcCtD
Carfilzomib—Hypoaesthesia—Etoposide—germ cell cancer	0.00128	0.00448	CcSEcCtD
Carfilzomib—Leukopenia—Ifosfamide—germ cell cancer	0.00127	0.00444	CcSEcCtD
Carfilzomib—Infection—Dactinomycin—germ cell cancer	0.00126	0.00439	CcSEcCtD
Carfilzomib—Hepatic failure—Methotrexate—germ cell cancer	0.00124	0.00434	CcSEcCtD
Carfilzomib—Cough—Ifosfamide—germ cell cancer	0.00124	0.00433	CcSEcCtD
Carfilzomib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00124	0.00433	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00123	0.00432	CcSEcCtD
Carfilzomib—Hypertension—Ifosfamide—germ cell cancer	0.00122	0.00429	CcSEcCtD
Carfilzomib—Dyspnoea—Bleomycin—germ cell cancer	0.00121	0.00423	CcSEcCtD
Carfilzomib—Arthralgia—Ifosfamide—germ cell cancer	0.00121	0.00423	CcSEcCtD
Carfilzomib—Renal failure acute—Methotrexate—germ cell cancer	0.00121	0.00422	CcSEcCtD
Carfilzomib—Anorexia—Dactinomycin—germ cell cancer	0.0012	0.00422	CcSEcCtD
Carfilzomib—Cardiac disorder—Etoposide—germ cell cancer	0.00119	0.00418	CcSEcCtD
Carfilzomib—Decreased appetite—Bleomycin—germ cell cancer	0.00118	0.00412	CcSEcCtD
Carfilzomib—Muscle spasms—Cisplatin—germ cell cancer	0.00118	0.00412	CcSEcCtD
Carfilzomib—Pain—Bleomycin—germ cell cancer	0.00116	0.00405	CcSEcCtD
Carfilzomib—Chills—Etoposide—germ cell cancer	0.00115	0.00404	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00115	0.00403	CcSEcCtD
Carfilzomib—Asthenia—Vinblastine—germ cell cancer	0.00115	0.00403	CcSEcCtD
Carfilzomib—Infection—Ifosfamide—germ cell cancer	0.00115	0.00403	CcSEcCtD
Carfilzomib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00113	0.00397	CcSEcCtD
Carfilzomib—Anaemia—Cisplatin—germ cell cancer	0.00113	0.00396	CcSEcCtD
Carfilzomib—Anorexia—Ifosfamide—germ cell cancer	0.0011	0.00386	CcSEcCtD
Carfilzomib—Decreased appetite—Dactinomycin—germ cell cancer	0.0011	0.00384	CcSEcCtD
Carfilzomib—Diarrhoea—Vinblastine—germ cell cancer	0.0011	0.00384	CcSEcCtD
Carfilzomib—Leukopenia—Cisplatin—germ cell cancer	0.00109	0.00383	CcSEcCtD
Carfilzomib—Fatigue—Dactinomycin—germ cell cancer	0.00109	0.00381	CcSEcCtD
Carfilzomib—Back pain—Etoposide—germ cell cancer	0.00108	0.00379	CcSEcCtD
Carfilzomib—Pain—Dactinomycin—germ cell cancer	0.00108	0.00378	CcSEcCtD
Carfilzomib—Muscle spasms—Etoposide—germ cell cancer	0.00108	0.00377	CcSEcCtD
Carfilzomib—Body temperature increased—Bleomycin—germ cell cancer	0.00107	0.00375	CcSEcCtD
Carfilzomib—Dizziness—Vinblastine—germ cell cancer	0.00106	0.00371	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00105	0.00369	CcSEcCtD
Carfilzomib—Anaemia—Etoposide—germ cell cancer	0.00104	0.00362	CcSEcCtD
Carfilzomib—Dyspnoea—Ifosfamide—germ cell cancer	0.00103	0.00361	CcSEcCtD
Carfilzomib—Vomiting—Vinblastine—germ cell cancer	0.00102	0.00357	CcSEcCtD
Carfilzomib—Decreased appetite—Ifosfamide—germ cell cancer	0.00101	0.00352	CcSEcCtD
Carfilzomib—Headache—Vinblastine—germ cell cancer	0.001	0.00352	CcSEcCtD
Carfilzomib—Leukopenia—Etoposide—germ cell cancer	0.001	0.00351	CcSEcCtD
Carfilzomib—Body temperature increased—Dactinomycin—germ cell cancer	0.000999	0.0035	CcSEcCtD
Carfilzomib—Fatigue—Ifosfamide—germ cell cancer	0.000998	0.00349	CcSEcCtD
Carfilzomib—Infection—Cisplatin—germ cell cancer	0.000992	0.00347	CcSEcCtD
Carfilzomib—Constipation—Ifosfamide—germ cell cancer	0.00099	0.00347	CcSEcCtD
Carfilzomib—Pain—Ifosfamide—germ cell cancer	0.00099	0.00347	CcSEcCtD
Carfilzomib—Cough—Etoposide—germ cell cancer	0.000978	0.00342	CcSEcCtD
Carfilzomib—Thrombocytopenia—Cisplatin—germ cell cancer	0.000977	0.00342	CcSEcCtD
Carfilzomib—Asthenia—Bleomycin—germ cell cancer	0.000972	0.0034	CcSEcCtD
Carfilzomib—Hypertension—Etoposide—germ cell cancer	0.000967	0.00339	CcSEcCtD
Carfilzomib—Nausea—Vinblastine—germ cell cancer	0.000953	0.00333	CcSEcCtD
Carfilzomib—Anorexia—Cisplatin—germ cell cancer	0.000952	0.00333	CcSEcCtD
Carfilzomib—Body temperature increased—Ifosfamide—germ cell cancer	0.000915	0.0032	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000909	0.00318	CcSEcCtD
Carfilzomib—Infection—Etoposide—germ cell cancer	0.000909	0.00318	CcSEcCtD
Carfilzomib—Asthenia—Dactinomycin—germ cell cancer	0.000907	0.00317	CcSEcCtD
Carfilzomib—Neutropenia—Methotrexate—germ cell cancer	0.000901	0.00315	CcSEcCtD
Carfilzomib—Thrombocytopenia—Etoposide—germ cell cancer	0.000895	0.00313	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000895	0.00313	CcSEcCtD
Carfilzomib—ABCB1—trigeminal ganglion—germ cell cancer	0.00089	0.0027	CbGeAlD
Carfilzomib—Dyspnoea—Cisplatin—germ cell cancer	0.00089	0.00311	CcSEcCtD
Carfilzomib—Anorexia—Etoposide—germ cell cancer	0.000872	0.00305	CcSEcCtD
Carfilzomib—Decreased appetite—Cisplatin—germ cell cancer	0.000868	0.00304	CcSEcCtD
Carfilzomib—Diarrhoea—Dactinomycin—germ cell cancer	0.000865	0.00303	CcSEcCtD
Carfilzomib—Pneumonia—Methotrexate—germ cell cancer	0.000864	0.00302	CcSEcCtD
Carfilzomib—Vomiting—Bleomycin—germ cell cancer	0.000861	0.00301	CcSEcCtD
Carfilzomib—ABCB1—embryo—germ cell cancer	0.00086	0.0026	CbGeAlD
Carfilzomib—Pain—Cisplatin—germ cell cancer	0.000854	0.00299	CcSEcCtD
Carfilzomib—Renal failure—Methotrexate—germ cell cancer	0.000844	0.00295	CcSEcCtD
Carfilzomib—Asthenia—Ifosfamide—germ cell cancer	0.000831	0.00291	CcSEcCtD
Carfilzomib—Dyspnoea—Etoposide—germ cell cancer	0.000815	0.00285	CcSEcCtD
Carfilzomib—Nausea—Bleomycin—germ cell cancer	0.000805	0.00282	CcSEcCtD
Carfilzomib—Vomiting—Dactinomycin—germ cell cancer	0.000803	0.00281	CcSEcCtD
Carfilzomib—Decreased appetite—Etoposide—germ cell cancer	0.000795	0.00278	CcSEcCtD
Carfilzomib—Diarrhoea—Ifosfamide—germ cell cancer	0.000792	0.00277	CcSEcCtD
Carfilzomib—Body temperature increased—Cisplatin—germ cell cancer	0.000789	0.00276	CcSEcCtD
Carfilzomib—Fatigue—Etoposide—germ cell cancer	0.000788	0.00276	CcSEcCtD
Carfilzomib—Constipation—Etoposide—germ cell cancer	0.000782	0.00274	CcSEcCtD
Carfilzomib—Pain—Etoposide—germ cell cancer	0.000782	0.00274	CcSEcCtD
Carfilzomib—Dizziness—Ifosfamide—germ cell cancer	0.000766	0.00268	CcSEcCtD
Carfilzomib—ABCB1—retina—germ cell cancer	0.00076	0.0023	CbGeAlD
Carfilzomib—Nausea—Dactinomycin—germ cell cancer	0.000751	0.00263	CcSEcCtD
Carfilzomib—Vomiting—Ifosfamide—germ cell cancer	0.000736	0.00258	CcSEcCtD
Carfilzomib—Body temperature increased—Etoposide—germ cell cancer	0.000723	0.00253	CcSEcCtD
Carfilzomib—Asthenia—Cisplatin—germ cell cancer	0.000716	0.00251	CcSEcCtD
Carfilzomib—Cardiac disorder—Methotrexate—germ cell cancer	0.000716	0.0025	CcSEcCtD
Carfilzomib—ABCB1—telencephalon—germ cell cancer	0.000699	0.00212	CbGeAlD
Carfilzomib—Chills—Methotrexate—germ cell cancer	0.000692	0.00242	CcSEcCtD
Carfilzomib—Nausea—Ifosfamide—germ cell cancer	0.000688	0.00241	CcSEcCtD
Carfilzomib—Diarrhoea—Cisplatin—germ cell cancer	0.000683	0.00239	CcSEcCtD
Carfilzomib—ABCB1—decidua—germ cell cancer	0.000663	0.00201	CbGeAlD
Carfilzomib—Asthenia—Etoposide—germ cell cancer	0.000656	0.0023	CcSEcCtD
Carfilzomib—Back pain—Methotrexate—germ cell cancer	0.000649	0.00227	CcSEcCtD
Carfilzomib—Vomiting—Cisplatin—germ cell cancer	0.000635	0.00222	CcSEcCtD
Carfilzomib—Diarrhoea—Etoposide—germ cell cancer	0.000626	0.00219	CcSEcCtD
Carfilzomib—Anaemia—Methotrexate—germ cell cancer	0.00062	0.00217	CcSEcCtD
Carfilzomib—Dizziness—Etoposide—germ cell cancer	0.000605	0.00212	CcSEcCtD
Carfilzomib—Leukopenia—Methotrexate—germ cell cancer	0.000601	0.0021	CcSEcCtD
Carfilzomib—Nausea—Cisplatin—germ cell cancer	0.000593	0.00208	CcSEcCtD
Carfilzomib—Cough—Methotrexate—germ cell cancer	0.000586	0.00205	CcSEcCtD
Carfilzomib—ABCB1—gonad—germ cell cancer	0.000584	0.00177	CbGeAlD
Carfilzomib—Vomiting—Etoposide—germ cell cancer	0.000581	0.00203	CcSEcCtD
Carfilzomib—ABCB1—uterus—germ cell cancer	0.00058	0.00176	CbGeAlD
Carfilzomib—Headache—Etoposide—germ cell cancer	0.000573	0.002	CcSEcCtD
Carfilzomib—Arthralgia—Methotrexate—germ cell cancer	0.000571	0.002	CcSEcCtD
Carfilzomib—ABCB1—pituitary gland—germ cell cancer	0.000569	0.00172	CbGeAlD
Carfilzomib—ABCB1—medulla oblongata—germ cell cancer	0.000549	0.00166	CbGeAlD
Carfilzomib—Infection—Methotrexate—germ cell cancer	0.000544	0.0019	CcSEcCtD
Carfilzomib—Nausea—Etoposide—germ cell cancer	0.000543	0.0019	CcSEcCtD
Carfilzomib—Thrombocytopenia—Methotrexate—germ cell cancer	0.000536	0.00188	CcSEcCtD
Carfilzomib—Anorexia—Methotrexate—germ cell cancer	0.000522	0.00183	CcSEcCtD
Carfilzomib—ABCB1—adrenal gland—germ cell cancer	0.000509	0.00154	CbGeAlD
Carfilzomib—ABCB1—midbrain—germ cell cancer	0.000502	0.00152	CbGeAlD
Carfilzomib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000499	0.00175	CcSEcCtD
Carfilzomib—Insomnia—Methotrexate—germ cell cancer	0.000495	0.00173	CcSEcCtD
Carfilzomib—ABCB1—bone marrow—germ cell cancer	0.000492	0.00149	CbGeAlD
Carfilzomib—ABCB1—spinal cord—germ cell cancer	0.00049	0.00148	CbGeAlD
Carfilzomib—Dyspnoea—Methotrexate—germ cell cancer	0.000488	0.00171	CcSEcCtD
Carfilzomib—Decreased appetite—Methotrexate—germ cell cancer	0.000476	0.00167	CcSEcCtD
Carfilzomib—ABCB1—female gonad—germ cell cancer	0.000474	0.00144	CbGeAlD
Carfilzomib—Fatigue—Methotrexate—germ cell cancer	0.000472	0.00165	CcSEcCtD
Carfilzomib—Pain—Methotrexate—germ cell cancer	0.000468	0.00164	CcSEcCtD
Carfilzomib—ABCB1—endocrine gland—germ cell cancer	0.000441	0.00134	CbGeAlD
Carfilzomib—ABCB1—head—germ cell cancer	0.000435	0.00132	CbGeAlD
Carfilzomib—Body temperature increased—Methotrexate—germ cell cancer	0.000433	0.00152	CcSEcCtD
Carfilzomib—ABCB1—testis—germ cell cancer	0.000421	0.00127	CbGeAlD
Carfilzomib—Asthenia—Methotrexate—germ cell cancer	0.000393	0.00138	CcSEcCtD
Carfilzomib—ABCB1—cerebellum—germ cell cancer	0.000389	0.00118	CbGeAlD
Carfilzomib—Diarrhoea—Methotrexate—germ cell cancer	0.000375	0.00131	CcSEcCtD
Carfilzomib—PSMB8—Cell Cycle Checkpoints—TP53—germ cell cancer	0.000365	0.00171	CbGpPWpGaD
Carfilzomib—Dizziness—Methotrexate—germ cell cancer	0.000362	0.00127	CcSEcCtD
Carfilzomib—PSMB10—TCF dependent signaling in response to WNT—MYC—germ cell cancer	0.000361	0.00169	CbGpPWpGaD
Carfilzomib—PSMB9—TCF dependent signaling in response to WNT—MYC—germ cell cancer	0.00036	0.00169	CbGpPWpGaD
Carfilzomib—PSMB10—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000351	0.00165	CbGpPWpGaD
Carfilzomib—PSMB10—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	0.00035	0.00164	CbGpPWpGaD
Carfilzomib—PSMB9—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.00035	0.00164	CbGpPWpGaD
Carfilzomib—Vomiting—Methotrexate—germ cell cancer	0.000348	0.00122	CcSEcCtD
Carfilzomib—PSMB9—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	0.000348	0.00163	CbGpPWpGaD
Carfilzomib—Headache—Methotrexate—germ cell cancer	0.000343	0.0012	CcSEcCtD
Carfilzomib—PSMB10—Metabolism—CRABP1—germ cell cancer	0.000339	0.00159	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CRABP1—germ cell cancer	0.000337	0.00158	CbGpPWpGaD
Carfilzomib—Nausea—Methotrexate—germ cell cancer	0.000325	0.00114	CcSEcCtD
Carfilzomib—PSMB10—Signaling by WNT in cancer—MYC—germ cell cancer	0.000325	0.00152	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by WNT in cancer—MYC—germ cell cancer	0.000323	0.00152	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—KITLG—germ cell cancer	0.000321	0.00151	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—KITLG—germ cell cancer	0.000321	0.00151	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—KITLG—germ cell cancer	0.000321	0.00151	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—SLC2A3—germ cell cancer	0.00032	0.0015	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—SLC2A3—germ cell cancer	0.00032	0.0015	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—SLC2A3—germ cell cancer	0.00032	0.0015	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—KITLG—germ cell cancer	0.000317	0.00149	CbGpPWpGaD
Carfilzomib—ABCB1—brain—germ cell cancer	0.000316	0.000956	CbGeAlD
Carfilzomib—PSMB10—Adaptive Immune System—FGFR3—germ cell cancer	0.000315	0.00148	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—SLC2A3—germ cell cancer	0.000315	0.00148	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—SLC22A3—germ cell cancer	0.000315	0.00148	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—SLC22A3—germ cell cancer	0.000315	0.00148	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—SLC22A3—germ cell cancer	0.000315	0.00148	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—FGFR3—germ cell cancer	0.000314	0.00147	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—FGF4—germ cell cancer	0.000313	0.00147	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FGF4—germ cell cancer	0.000312	0.00146	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—SLC22A3—germ cell cancer	0.00031	0.00146	CbGpPWpGaD
Carfilzomib—PSMB10—B Cell Activation—HRAS—germ cell cancer	0.00031	0.00146	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—HRAS—germ cell cancer	0.000309	0.00145	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000307	0.00144	CbGpPWpGaD
Carfilzomib—ABCB1—lymph node—germ cell cancer	0.000305	0.000924	CbGeAlD
Carfilzomib—PSMB1—Apoptosis—TP53—germ cell cancer	0.000295	0.00139	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TP53—germ cell cancer	0.000295	0.00139	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TP53—germ cell cancer	0.000295	0.00139	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TP53—germ cell cancer	0.000291	0.00137	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—KIT—germ cell cancer	0.000289	0.00136	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—FGF4—germ cell cancer	0.000289	0.00136	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—KIT—germ cell cancer	0.000288	0.00135	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—FGF4—germ cell cancer	0.000288	0.00135	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—H2AFZ—germ cell cancer	0.000278	0.0013	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—H2AFZ—germ cell cancer	0.000277	0.0013	CbGpPWpGaD
Carfilzomib—PSMB5—TCF dependent signaling in response to WNT—MYC—germ cell cancer	0.000274	0.00128	CbGpPWpGaD
Carfilzomib—PSMB1—TCF dependent signaling in response to WNT—MYC—germ cell cancer	0.000274	0.00128	CbGpPWpGaD
Carfilzomib—PSMB2—TCF dependent signaling in response to WNT—MYC—germ cell cancer	0.000274	0.00128	CbGpPWpGaD
Carfilzomib—PSMB8—TCF dependent signaling in response to WNT—MYC—germ cell cancer	0.00027	0.00127	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling by Wnt—MYC—germ cell cancer	0.000268	0.00126	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by Wnt—MYC—germ cell cancer	0.000267	0.00125	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000266	0.00125	CbGpPWpGaD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000266	0.00125	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000266	0.00125	CbGpPWpGaD
Carfilzomib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	0.000266	0.00125	CbGpPWpGaD
Carfilzomib—PSMB1—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	0.000265	0.00124	CbGpPWpGaD
Carfilzomib—PSMB5—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	0.000265	0.00124	CbGpPWpGaD
Carfilzomib—PSMB2—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	0.000265	0.00124	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000262	0.00123	CbGpPWpGaD
Carfilzomib—PSMB8—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	0.000261	0.00123	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—H2AFZ—germ cell cancer	0.000258	0.00121	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—KITLG—germ cell cancer	0.000257	0.00121	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—H2AFZ—germ cell cancer	0.000257	0.00121	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CRABP1—germ cell cancer	0.000257	0.0012	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CRABP1—germ cell cancer	0.000257	0.0012	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CRABP1—germ cell cancer	0.000257	0.0012	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—KITLG—germ cell cancer	0.000256	0.0012	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CRABP1—germ cell cancer	0.000253	0.00119	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by WNT in cancer—MYC—germ cell cancer	0.000246	0.00115	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by WNT in cancer—MYC—germ cell cancer	0.000246	0.00115	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by WNT in cancer—MYC—germ cell cancer	0.000246	0.00115	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by WNT in cancer—MYC—germ cell cancer	0.000243	0.00114	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—FGFR3—germ cell cancer	0.000239	0.00112	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—FGFR3—germ cell cancer	0.000239	0.00112	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—FGFR3—germ cell cancer	0.000239	0.00112	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—KITLG—germ cell cancer	0.000238	0.00111	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGF4—germ cell cancer	0.000237	0.00111	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGF4—germ cell cancer	0.000237	0.00111	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGF4—germ cell cancer	0.000237	0.00111	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—OXT—germ cell cancer	0.000237	0.00111	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—KITLG—germ cell cancer	0.000236	0.00111	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—OXT—germ cell cancer	0.000236	0.00111	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—FGFR3—germ cell cancer	0.000236	0.0011	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—HRAS—germ cell cancer	0.000235	0.0011	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—HRAS—germ cell cancer	0.000235	0.0011	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—HRAS—germ cell cancer	0.000235	0.0011	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGF4—germ cell cancer	0.000234	0.0011	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—HRAS—germ cell cancer	0.000232	0.00109	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—KIT—germ cell cancer	0.000219	0.00103	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—KIT—germ cell cancer	0.000219	0.00103	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—KIT—germ cell cancer	0.000219	0.00103	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGF4—germ cell cancer	0.000219	0.00103	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—FGF4—germ cell cancer	0.000219	0.00103	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGF4—germ cell cancer	0.000219	0.00103	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—KIT—germ cell cancer	0.000216	0.00101	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGF4—germ cell cancer	0.000216	0.00101	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—H2AFZ—germ cell cancer	0.000211	0.000989	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—H2AFZ—germ cell cancer	0.000211	0.000989	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—H2AFZ—germ cell cancer	0.000211	0.000989	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—H2AFZ—germ cell cancer	0.000208	0.000975	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by Wnt—MYC—germ cell cancer	0.000203	0.000952	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by Wnt—MYC—germ cell cancer	0.000203	0.000952	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by Wnt—MYC—germ cell cancer	0.000203	0.000952	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGF4—germ cell cancer	0.000202	0.00095	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGF4—germ cell cancer	0.000201	0.000945	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000201	0.000941	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by Wnt—MYC—germ cell cancer	0.0002	0.000939	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000198	0.000927	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—H2AFZ—germ cell cancer	0.000196	0.000918	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—H2AFZ—germ cell cancer	0.000196	0.000918	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—H2AFZ—germ cell cancer	0.000196	0.000918	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—KITLG—germ cell cancer	0.000195	0.000915	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—KITLG—germ cell cancer	0.000195	0.000915	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—KITLG—germ cell cancer	0.000195	0.000915	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle, Mitotic—MYC—germ cell cancer	0.000194	0.000912	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle, Mitotic—MYC—germ cell cancer	0.000194	0.000908	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—H2AFZ—germ cell cancer	0.000193	0.000905	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—KITLG—germ cell cancer	0.000192	0.000902	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—FGFR3—germ cell cancer	0.000191	0.000897	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FGFR3—germ cell cancer	0.00019	0.000893	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—H2AFZ—germ cell cancer	0.000181	0.000848	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—KITLG—germ cell cancer	0.00018	0.000844	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—KITLG—germ cell cancer	0.00018	0.000844	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—KITLG—germ cell cancer	0.00018	0.000844	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—H2AFZ—germ cell cancer	0.00018	0.000844	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—OXT—germ cell cancer	0.00018	0.000843	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—OXT—germ cell cancer	0.00018	0.000843	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—OXT—germ cell cancer	0.00018	0.000843	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—KITLG—germ cell cancer	0.000177	0.000833	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—OXT—germ cell cancer	0.000177	0.000831	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—FGFR3—germ cell cancer	0.000177	0.000828	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—FGFR3—germ cell cancer	0.000176	0.000824	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—KIT—germ cell cancer	0.000176	0.000823	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—KIT—germ cell cancer	0.000175	0.00082	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—MYC—germ cell cancer	0.000174	0.000816	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HRAS—germ cell cancer	0.000174	0.000814	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—MYC—germ cell cancer	0.000173	0.000812	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—KITLG—germ cell cancer	0.000166	0.00078	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—KITLG—germ cell cancer	0.000166	0.000777	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AVP—germ cell cancer	0.000163	0.000763	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—KIT—germ cell cancer	0.000162	0.00076	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AVP—germ cell cancer	0.000162	0.000759	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—KIT—germ cell cancer	0.000161	0.000757	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF4—germ cell cancer	0.000153	0.00072	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF4—germ cell cancer	0.000153	0.00072	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF4—germ cell cancer	0.000153	0.00072	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF4—germ cell cancer	0.000151	0.00071	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle, Mitotic—MYC—germ cell cancer	0.000147	0.000691	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle, Mitotic—MYC—germ cell cancer	0.000147	0.000691	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle, Mitotic—MYC—germ cell cancer	0.000147	0.000691	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle, Mitotic—MYC—germ cell cancer	0.000145	0.000681	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGFR3—germ cell cancer	0.000145	0.00068	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGFR3—germ cell cancer	0.000145	0.00068	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGFR3—germ cell cancer	0.000145	0.00068	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGFR3—germ cell cancer	0.000143	0.00067	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—germ cell cancer	0.000143	0.00067	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—germ cell cancer	0.000142	0.000667	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—H2AFZ—germ cell cancer	0.000137	0.000643	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—H2AFZ—germ cell cancer	0.000137	0.000643	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—H2AFZ—germ cell cancer	0.000137	0.000643	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—H2AFZ—germ cell cancer	0.000135	0.000634	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—FGFR3—germ cell cancer	0.000134	0.000628	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGFR3—germ cell cancer	0.000134	0.000628	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGFR3—germ cell cancer	0.000134	0.000628	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—KIT—germ cell cancer	0.000133	0.000624	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—KIT—germ cell cancer	0.000133	0.000624	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—KIT—germ cell cancer	0.000133	0.000624	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGFR3—germ cell cancer	0.000132	0.000619	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—MYC—germ cell cancer	0.000132	0.000618	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—MYC—germ cell cancer	0.000132	0.000618	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—MYC—germ cell cancer	0.000132	0.000618	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—KIT—germ cell cancer	0.000131	0.000615	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—MYC—germ cell cancer	0.00013	0.000609	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—KITLG—germ cell cancer	0.000126	0.000591	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KITLG—germ cell cancer	0.000126	0.000591	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KITLG—germ cell cancer	0.000126	0.000591	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HRAS—germ cell cancer	0.000125	0.000587	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HRAS—germ cell cancer	0.000124	0.000584	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KITLG—germ cell cancer	0.000124	0.000583	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGFR3—germ cell cancer	0.000124	0.00058	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AVP—germ cell cancer	0.000123	0.000578	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AVP—germ cell cancer	0.000123	0.000578	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AVP—germ cell cancer	0.000123	0.000578	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGFR3—germ cell cancer	0.000123	0.000577	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—KIT—germ cell cancer	0.000123	0.000576	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—KIT—germ cell cancer	0.000123	0.000576	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—KIT—germ cell cancer	0.000123	0.000576	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AVP—germ cell cancer	0.000121	0.00057	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—KIT—germ cell cancer	0.000121	0.000568	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—KIT—germ cell cancer	0.000114	0.000532	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—KIT—germ cell cancer	0.000113	0.00053	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—germ cell cancer	0.000108	0.000508	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—germ cell cancer	0.000108	0.000508	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—germ cell cancer	0.000108	0.000508	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—germ cell cancer	0.000107	0.0005	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—MYC—germ cell cancer	9.61e-05	0.000451	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—MYC—germ cell cancer	9.56e-05	0.000448	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HRAS—germ cell cancer	9.48e-05	0.000445	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HRAS—germ cell cancer	9.48e-05	0.000445	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HRAS—germ cell cancer	9.48e-05	0.000445	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC2A3—germ cell cancer	9.4e-05	0.000441	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGFR3—germ cell cancer	9.37e-05	0.000439	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGFR3—germ cell cancer	9.37e-05	0.000439	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGFR3—germ cell cancer	9.37e-05	0.000439	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HRAS—germ cell cancer	9.35e-05	0.000438	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC22A3—germ cell cancer	9.26e-05	0.000434	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	9.26e-05	0.000434	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGFR3—germ cell cancer	9.24e-05	0.000433	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	8.95e-05	0.00042	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—MYC—germ cell cancer	8.92e-05	0.000418	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—MYC—germ cell cancer	8.88e-05	0.000416	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KIT—germ cell cancer	8.6e-05	0.000403	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KIT—germ cell cancer	8.6e-05	0.000403	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—KIT—germ cell cancer	8.6e-05	0.000403	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KIT—germ cell cancer	8.48e-05	0.000398	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HRAS—germ cell cancer	7.59e-05	0.000356	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HRAS—germ cell cancer	7.55e-05	0.000354	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CRABP1—germ cell cancer	7.55e-05	0.000354	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	7.35e-05	0.000345	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—MYC—germ cell cancer	7.28e-05	0.000341	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—MYC—germ cell cancer	7.28e-05	0.000341	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—MYC—germ cell cancer	7.28e-05	0.000341	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—MYC—germ cell cancer	7.18e-05	0.000337	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—HRAS—germ cell cancer	7e-05	0.000329	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—HRAS—germ cell cancer	6.97e-05	0.000327	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MYC—germ cell cancer	6.76e-05	0.000317	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MYC—germ cell cancer	6.76e-05	0.000317	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MYC—germ cell cancer	6.76e-05	0.000317	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MYC—germ cell cancer	6.66e-05	0.000313	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MYC—germ cell cancer	6.25e-05	0.000293	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MYC—germ cell cancer	6.22e-05	0.000292	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HRAS—germ cell cancer	5.75e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HRAS—germ cell cancer	5.75e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HRAS—germ cell cancer	5.75e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HRAS—germ cell cancer	5.67e-05	0.000266	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—HRAS—germ cell cancer	5.31e-05	0.000249	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—HRAS—germ cell cancer	5.31e-05	0.000249	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—HRAS—germ cell cancer	5.31e-05	0.000249	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—HRAS—germ cell cancer	5.23e-05	0.000246	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—germ cell cancer	5.13e-05	0.000241	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—germ cell cancer	5.1e-05	0.000239	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—HRAS—germ cell cancer	4.91e-05	0.00023	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—HRAS—germ cell cancer	4.88e-05	0.000229	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MYC—germ cell cancer	4.73e-05	0.000222	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MYC—germ cell cancer	4.73e-05	0.000222	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MYC—germ cell cancer	4.73e-05	0.000222	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MYC—germ cell cancer	4.67e-05	0.000219	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—germ cell cancer	3.89e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—germ cell cancer	3.89e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—germ cell cancer	3.89e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—germ cell cancer	3.83e-05	0.00018	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HRAS—germ cell cancer	3.72e-05	0.000174	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HRAS—germ cell cancer	3.72e-05	0.000174	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HRAS—germ cell cancer	3.72e-05	0.000174	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HRAS—germ cell cancer	3.66e-05	0.000172	CbGpPWpGaD
